Cattle - Single-Dose Therapy: Baytril® 100 (enrofloxacin) Injectable is indicated for
the treatment of bovine respiratory disease (BRD) associated with Mannheimia
haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma
bovis in beef and non-lactating dairy cattle; and for the control of BRD in
beef and non-lactating dairy cattle at high risk of developing BRD associated
with M. haemolytica, P. multocida, H. somni and M. bovis.
Cattle - Multiple-Day Therapy: Baytril 100 is indicated for the treatment
of bovine respiratory disease (BRD) associated with Mannheimia haemolytica,
Pasteurella multocida and Histophilus somni in beef and
non-lactating dairy cattle.
Swine: Baytril 100 is indicated for the treatment and control of swine
respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae,
Pasteurella multocida, Haemophilus parasuis, Streptococcus suis, Bordetella
bronchiseptica and Mycoplasma hyopneumoniae. Baytril 100 is
indicated for the control of colibacillosis in groups or pens of weaned pigs
where colibacillosis associated with Escherichia coli has been
diagnosed.
Storage and Disposal
Protect from direct sunlight. Do not refrigerate or freeze. Store at 20-30ºC
(68-86ºF), excursions permitted up to 40ºC (104ºF). Precipitation may occur due
to cold temperature. To redissolve, warm and then shake the vial.
Dosage Information
Baytril 100 provides flexible dosages and durations of therapy.
Baytril 100 may be administered as a single dose for one day for
treatment and control of BRD (cattle), for treatment and control of SRD or for
control of colibacillosis (swine), or for multiple days for BRD treatment
(cattle). Selection of the appropriate dose and duration of therapy for BRD
treatment in cattle should be based on an assessment of the severity of the
disease, pathogen susceptibility and clinical response.
Cattle:
Single-Dose Therapy (BRD Treatment): Administer, by subcutaneous injection,
a single dose of 7.5-12.5 mg/kg of body weight (3.4-5.7 mL/100 lb).
Multiple-Day Therapy (BRD Treatment):
Administer daily, a subcutaneous dose
of 2.5-5 mg/kg of body weight (1.1-2.3 mL/100 lb).
Treatment should be repeated at 24-hour intervals for three days.
Additional treatments may be given on Days 4 and 5 to animals that have shown
clinical improvement but not total recovery.
Single-Dose Therapy (BRD Control): Administer, by subcutaneous injection, a single dose of 7.5 mg/kg
of body weight (3.4 mL/100 lb).